According to Jaguar Health's latest financial reports and stock price the company's current Operating Margin is -404.77%. At the end of 2021 the company had an Operating Margin of -1,213.38%.
Year | Operating Margin | Change |
---|---|---|
2021 | -1,213.38% | 236.82% |
2020 | -360.25% | -46% |
2019 | -667.15% | -8.35% |
2018 | -727.92% | -9.68% |
2017 | -805.97% | -92.26% |
2016 | -10,410.87% | 65.11% |
2015 | -6,305.24% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Lifevantage LFVN | 0.00% | N/A | ๐บ๐ธ USA |
Taro Pharmaceutical TARO | 13.86% | -103.42% | ๐ฎ๐ฑ Israel |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.